HRP20200372T1 - Postupci proizvodnje poloksamera za upotrebu u mediju za staničnu kulturu - Google Patents

Postupci proizvodnje poloksamera za upotrebu u mediju za staničnu kulturu Download PDF

Info

Publication number
HRP20200372T1
HRP20200372T1 HRP20200372TT HRP20200372T HRP20200372T1 HR P20200372 T1 HRP20200372 T1 HR P20200372T1 HR P20200372T T HRP20200372T T HR P20200372TT HR P20200372 T HRP20200372 T HR P20200372T HR P20200372 T1 HRP20200372 T1 HR P20200372T1
Authority
HR
Croatia
Prior art keywords
poloxamer
minutes
heated
cell
culture medium
Prior art date
Application number
HRP20200372TT
Other languages
English (en)
Croatian (hr)
Inventor
Ganesh Prasadh Vissvesvaran
Robert David Kiss
Steven J. Meier
Inchan Kwon
Kara Calhoun
Kate WINCHESTER
Amelia ADAMS
Marion GLENN
Stefan Koenig
Alan Deese
Original Assignee
F. Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag
Publication of HRP20200372T1 publication Critical patent/HRP20200372T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/30Post-polymerisation treatment, e.g. recovery, purification, drying
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/02General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/48Polymers modified by chemical after-treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/10Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14Specific host cells or culture conditions, e.g. components, pH or temperature
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2650/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G2650/28Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
    • C08G2650/50Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type containing nitrogen, e.g. polyetheramines or Jeffamines(r)
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2650/00Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G2650/28Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule characterised by the polymer type
    • C08G2650/58Ethylene oxide or propylene oxide copolymers, e.g. pluronics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/50Soluble polymers, e.g. polyethyleneglycol [PEG]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Peptides Or Proteins (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
HRP20200372TT 2014-03-25 2015-03-25 Postupci proizvodnje poloksamera za upotrebu u mediju za staničnu kulturu HRP20200372T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461970281P 2014-03-25 2014-03-25
PCT/US2015/022592 WO2015148736A1 (en) 2014-03-25 2015-03-25 Methods of preparing a poloxamer for use in cell culture medium
EP15715932.8A EP3122799B8 (en) 2014-03-25 2015-03-25 Methods of preparing a poloxamer for use in cell culture medium

Publications (1)

Publication Number Publication Date
HRP20200372T1 true HRP20200372T1 (hr) 2020-06-12

Family

ID=52824596

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20200372TT HRP20200372T1 (hr) 2014-03-25 2015-03-25 Postupci proizvodnje poloksamera za upotrebu u mediju za staničnu kulturu

Country Status (19)

Country Link
US (2) US11034793B2 (cg-RX-API-DMAC7.html)
EP (2) EP3122799B8 (cg-RX-API-DMAC7.html)
JP (3) JP6655548B2 (cg-RX-API-DMAC7.html)
KR (1) KR102352250B1 (cg-RX-API-DMAC7.html)
CN (2) CN106414552B (cg-RX-API-DMAC7.html)
AU (1) AU2015236008B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016021739B1 (cg-RX-API-DMAC7.html)
CA (1) CA2943357C (cg-RX-API-DMAC7.html)
ES (1) ES2778680T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20200372T1 (cg-RX-API-DMAC7.html)
IL (2) IL247902B (cg-RX-API-DMAC7.html)
MX (2) MX2016012288A (cg-RX-API-DMAC7.html)
MY (1) MY178060A (cg-RX-API-DMAC7.html)
PL (1) PL3122799T3 (cg-RX-API-DMAC7.html)
RU (1) RU2710551C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201607929PA (cg-RX-API-DMAC7.html)
SI (1) SI3122799T1 (cg-RX-API-DMAC7.html)
WO (1) WO2015148736A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201606711B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3122799B8 (en) 2014-03-25 2020-03-11 F.Hoffmann-La Roche Ag Methods of preparing a poloxamer for use in cell culture medium
WO2017157505A1 (en) 2016-03-17 2017-09-21 Merck Patent Gmbh Method for purifying poloxamers
SG11202002351SA (en) * 2017-12-21 2020-07-29 Sigma Aldrich Co Llc Poloxamer compositions and methods of making and using same
WO2020013725A1 (en) * 2018-07-12 2020-01-16 Arshintseva Elena Valentinovna Thermal method for sterilizing poloxamer comprising liquid drugs
KR102853452B1 (ko) * 2018-07-27 2025-09-03 아지노모토 가부시키가이샤 동물 세포의 부유 배양용 첨가물, 부유 배양용 배지 및 부유 배양 방법

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE266710C (cg-RX-API-DMAC7.html)
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
DD266710A3 (de) 1983-06-06 1989-04-12 Ve Forschungszentrum Biotechnologie Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
EP0402226A1 (en) 1989-06-06 1990-12-12 Institut National De La Recherche Agronomique Transformation vectors for yeast yarrowia
US5959177A (en) 1989-10-27 1999-09-28 The Scripps Research Institute Transgenic plants expressing assembled secretory antibodies
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
WO1992003918A1 (en) 1990-08-29 1992-03-19 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
AU2699892A (en) 1991-10-04 1993-05-03 Gs Biochem Ab Particles, method of preparing said particles and uses thereof
DK0754050T3 (da) 1994-01-14 2002-10-21 Xoma Technology Ltd Anti-gram-positive bakterielle fremgangsmåder og materialer
US5912228A (en) * 1995-01-13 1999-06-15 Xoma Corporation Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
ATE390933T1 (de) 1995-04-27 2008-04-15 Amgen Fremont Inc Aus immunisierten xenomäusen stammende menschliche antikörper gegen il-8
WO1996034096A1 (en) 1995-04-28 1996-10-31 Abgenix, Inc. Human antibodies derived from immunized xenomice
CA2722378C (en) 1996-12-03 2015-02-03 Amgen Fremont Inc. Human antibodies that bind tnf.alpha.
GB9625175D0 (en) * 1996-12-04 1997-01-22 Medi Cult As Serum-free cell culture media
US5804420A (en) 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6040498A (en) 1998-08-11 2000-03-21 North Caroline State University Genetically engineered duckweed
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
ES2248127T3 (es) 1999-10-04 2006-03-16 Medicago Inc. Metodo para regular la transcripcion de genes foraneos en presencia de nigtrogeno.
TWI367113B (en) * 2003-02-12 2012-07-01 Syncera Inc Random and non-random alkylene oxide polymer alloy compositions
US8802116B2 (en) * 2003-02-27 2014-08-12 Novasel Australia Pty. Ltd. Poloxamer emulsion preparations
AU2003900887A0 (en) * 2003-02-27 2003-03-13 Novasel Australia Pty Ltd Poloxamer emulsion preparations
EP1660227B1 (en) * 2003-08-04 2012-05-23 Camurus Ab Method for improving the properties of amphiphile particles
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
US20060121016A1 (en) 2004-10-18 2006-06-08 Lee Raphael C Methods and compositions for treatment of free radical injury
US9149433B2 (en) * 2004-11-30 2015-10-06 Basf Corporation Method for formation of micro-prilled polymers
CN1939534B (zh) 2005-09-27 2010-12-01 长春金赛药业股份有限公司 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
CN101516339B (zh) 2006-08-16 2012-06-13 诺瓦提斯公司 制备高度结晶的治疗化合物的固体分散体的方法
KR100932613B1 (ko) 2007-04-27 2009-12-17 한남대학교 산학협력단 고분자 용융공정을 이용한 약물전달용 생체적합성 고분자나노 미립구의 제조방법 및 그 나노 미립구
WO2009055312A1 (en) * 2007-10-22 2009-04-30 Dfb Pharmaceuticals, Inc. Process for producing a poloxamer gel
PT2574677T (pt) 2007-12-27 2017-10-19 Baxalta Inc Processos para cultura de células
BR112012015596B1 (pt) * 2009-12-23 2021-06-01 Sanofi Pasteur Processo de cultura de células aderentes
EP2830598B1 (en) * 2012-03-30 2016-11-09 INSERM (Institut National de la Santé et de la Recherche Médicale) Microsphere compositions, preparation method and applications thereof
EP3122799B8 (en) 2014-03-25 2020-03-11 F.Hoffmann-La Roche Ag Methods of preparing a poloxamer for use in cell culture medium

Also Published As

Publication number Publication date
CN111808276A (zh) 2020-10-23
CN106414552B (zh) 2020-08-25
WO2015148736A1 (en) 2015-10-01
PL3122799T3 (pl) 2020-06-29
BR112016021739B1 (pt) 2021-11-03
ZA201606711B (en) 2019-12-18
BR112016021739A2 (pt) 2017-08-15
IL247902A0 (en) 2016-11-30
SI3122799T1 (sl) 2020-06-30
US20170009015A1 (en) 2017-01-12
KR20160138161A (ko) 2016-12-02
MY178060A (en) 2020-09-30
US11034793B2 (en) 2021-06-15
JP2023011566A (ja) 2023-01-24
CA2943357A1 (en) 2015-10-01
AU2015236008B2 (en) 2018-12-20
KR102352250B1 (ko) 2022-01-17
RU2016141568A3 (cg-RX-API-DMAC7.html) 2018-09-26
ES2778680T3 (es) 2020-08-11
CA2943357C (en) 2023-06-27
NZ725151A (en) 2021-05-28
JP6655548B2 (ja) 2020-02-26
JP2020103290A (ja) 2020-07-09
EP3778702B1 (en) 2023-06-28
IL279583B (en) 2022-03-01
MX2016012288A (es) 2017-01-23
SG11201607929PA (en) 2016-10-28
EP3122799B8 (en) 2020-03-11
JP2017516459A (ja) 2017-06-22
US20210371587A1 (en) 2021-12-02
RU2016141568A (ru) 2018-04-28
EP3122799A1 (en) 2017-02-01
IL279583A (en) 2021-03-01
US11912823B2 (en) 2024-02-27
WO2015148736A8 (en) 2016-08-18
MX2021001981A (es) 2021-04-28
EP3122799B1 (en) 2020-01-15
IL247902B (en) 2021-01-31
EP3778702A1 (en) 2021-02-17
CN106414552A (zh) 2017-02-15
AU2015236008A1 (en) 2016-10-27
JP7472222B2 (ja) 2024-04-22
RU2710551C2 (ru) 2019-12-27

Similar Documents

Publication Publication Date Title
HRP20200372T1 (hr) Postupci proizvodnje poloksamera za upotrebu u mediju za staničnu kulturu
ZA202000373B (en) Anti-cd47 antibodies and uses thereof
JP2016536391A5 (cg-RX-API-DMAC7.html)
MX2016017017A (es) Proceso para la preparacion de una poliamida semi-aromatica, semi-cristalina.
EP2863426A4 (en) HEAT INTERFACE FILM, MANUFACTURING METHOD AND COOLING SYSTEM THEREFOR
MX2021015169A (es) Metodos de preparacion de un catalizador.
BR112013021486A2 (pt) lentes de contato de hidrogel contendo fosfina
WO2021073659A3 (zh) 一种基于阴离子聚合物及其衍生物制备的疫苗载体
BRPI1008338A2 (pt) processo para preparar uma composição de polímero, composiçãode polímero, uso de uma composição de polímero, e, filme
Sommer et al. Ultra-high temperature granulite-facies metamorphic rocks from the Mozambique belt of SW Tanzania
JP2017516459A5 (cg-RX-API-DMAC7.html)
BR112016030326A2 (pt) ?poliepítopo quimérico, polinucleotídeo, vetores, célula, partículas de vírus, composição imunogênica, método para prevenir e/ou tratar infecções e método de produção de partículas de mv?
SG195199A1 (en) Untitled
WO2014140901A3 (en) Directional solidification system and method
MX2017000136A (es) Metodo para revestir material de aleta de aluminio con pelicula hidrofilica, material de aleta de aluminio, e intercambiador de calor de aluminio.
MX368555B (es) Polipeptidos de fusion y vacunas.
WO2014197197A8 (en) High temperature geomembrane liners and master batch compositions
EP3342721A4 (en) Aligned structure of a bag container, manufacturing device therefor and manufacturing method therefor
RU2017109663A (ru) Цементная композиция и способ получения отвержденного цементного изделия с использованием этой композиции
Zhang et al. Isothermal crystallization kinetics of in situ Nylon 6/graphene composites by differential scanning calorimetry
RU2016105128A (ru) Способ сборки деталей турбомашины и узел, применяемый при таком способе
AR106919A1 (es) Proceso para reducir el empañamiento del propileno con alta resistencia a la fusión y formulación resultante
박종현 et al. Influence of Post-Thermal Treatment on the Thermal and Mechanical Properties of PEEK/CF Composites
MX394378B (es) Espuma de polietileno para alta temperatura sin enlaces cruzados y metodos para fabricarla.
Chae et al. Prevalence and characteristics of Salmonella spp